Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats (Q43286294)

scientific article published in January 2010

Language	Label	Description	Also known as
English	Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats	scientific article published in January 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

18 November 2017

Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats (English)

1 reference

stated in

Europe PubMed Central

18 November 2017

4

1 reference

stated in

Europe PubMed Central

18 November 2017

G Telegdy

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19706309

retrieved

18 November 2017

A Adamik

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19706309

retrieved

18 November 2017

M Tanaka

series ordinal

3

1 reference

stated in

Europe PubMed Central

18 November 2017

1 January 2010

1 reference

stated in

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

159

1 reference

stated in

Europe PubMed Central

18 November 2017

1-3

1 reference

stated in

Europe PubMed Central

18 November 2017

142-147

1 reference

stated in

Europe PubMed Central

18 November 2017

Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Administration of human chorionic gonadotropin affects sleep-wake phases and other associated behaviors in cycling female rats.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Evidence for the role of luteinizing hormone in Alzheimer disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Neuropharmacological actions of the superactive agonist analog D-TRP-6-LH-RH after peripheral injection into mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Hypothalamic Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH)-Regulating Hormone: Structure, Physiology, and Clinical Studies**The work described here has been supported by research grants from the Veterans Administration, United State

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Depressive symptoms, sex, and risk for Alzheimer's disease.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Partial reversal of behavioral action of the agonist D-Trp-6-LH-RH by naloxone in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The neurochemical and behavioral effects of beta-amyloid peptide(25-35)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Evidence for the role of gonadotropin hormones in the development of Alzheimer disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Effects of the LHRH antagonist Cetrorelix on the brain function in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Is any female preponderance in depression secondary to a primary female preponderance in anxiety disorders?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Memories are made of this: recent advances in understanding cognitive impairments and dementia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

LH-RH analogues: I. Their impact on reproductive medicine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Serum chorionic gonadotrophin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Leuprolide acetate: a drug of diverse clinical applications

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Motherhood and memory: a review

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The neuroprotective effects of estrogen on the aging brain.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Psychopathology in women and men: focus on female hormones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The LHRH antagonist cetrorelix: a review

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Rat as model for studying behavior effects of hCG.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Estrogen-mediated effects on depression and memory formation in females

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Role of estrogen in the aetiology and treatment of mood disorders

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Sex differences in depression: a role for preexisting anxiety

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Mood, cognition and Alzheimer's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Prolonged inhibition of luteinizing hormone and testosterone levels in male rats with the luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Hormonal profiles after the menopause

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Gonadotropin, ACTH, prolactin, sexual steroid and cortisol levels in postmenopausal women's cerebrospinal fluid (CSF).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

The gonadotropin connection in Alzheimer's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.REGPEP.2009.08.005

Identifiers

DOI

10.1016/J.REGPEP.2009.08.005

1 reference

stated in

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

PubMed ID

19706309

retrieved

18 November 2017

Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats (Q43286294)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats (Q43286294)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search